• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国华裔女性和白人女性的循环骨硬化蛋白水平和骨转换标志物。

Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.

机构信息

630 West 168th Street, PH8 West-864, New York, New York 10032.

出版信息

J Clin Endocrinol Metab. 2013 Dec;98(12):4736-43. doi: 10.1210/jc.2013-2106. Epub 2013 Sep 13.

DOI:10.1210/jc.2013-2106
PMID:24037879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3849675/
Abstract

CONTEXT

Chinese-American women have bone microarchitectural features that confer greater bone stiffness compared to white women, but the physiology underlying these findings has not been investigated.

OBJECTIVE

The purpose of the study was to assess racial differences in serum sclerostin and bone turnover markers (BTMs), and to explore their associations with each other, volumetric bone mineral density (BMD), and bone microarchitecture in Chinese-American and white women.

DESIGN AND SETTING

We conducted a cross-sectional study at a university hospital.

PARTICIPANTS

We studied 138 women.

RESULTS

Serum osteocalcin was 19-28% lower in pre- and postmenopausal Chinese-American vs white women, respectively (both P < .01). C-Terminal telopeptide of type I collagen (CTX) level was 18-22% lower in pre- and postmenopausal Chinese-American vs white women (both P < .05). Pre- vs postmenopausal differences in osteocalcin and CTX were greater in white vs Chinese-American women. Sclerostin levels were similar in both races, but BTMs were differentially associated with sclerostin by race and menopausal status. BTMs were not correlated with sclerostin in Chinese-Americans. CTX and bone-specific alkaline phosphatase were positively associated with sclerostin (r = 0.353, r = 0.458; both P < .05) in white premenopausal women. In contrast, in postmenopausal white women, the associations of sclerostin with amino-terminal propeptide of type I procollagen, isoform 5b of tartrate-resistant acid phosphatase, and CTX were negative (all P < .05). Adjusting for covariates, sclerostin was positively associated with areal BMD in both races.

CONCLUSIONS

Lower BTMs in Chinese-American women and greater age-related differences in BTMs among white women provide a physiological framework to account for racial differences in BMD, microarchitecture, and fracture.

摘要

背景

与白人女性相比,华裔美国女性具有赋予其更高骨刚性的骨骼微观结构特征,但这些发现背后的生理学机制尚未得到研究。

目的

本研究旨在评估华裔美国女性和白人女性之间血清硬化素和骨转换标志物(BTMs)的种族差异,并探讨它们彼此之间的关系以及与骨体积密度(BMD)和骨微观结构的关系。

设计和设置

我们在一所大学医院进行了一项横断面研究。

参与者

我们研究了 138 名女性。

结果

绝经前和绝经后华裔美国女性的血清骨钙素分别低 19-28%(均 P <.01)。绝经前和绝经后华裔美国女性的 I 型胶原 C 端肽(CTX)水平分别低 18-22%(均 P <.05)。绝经前和绝经后华裔美国女性的骨钙素和 CTX 与绝经前相比差异更大。两种种族的硬化素水平相似,但 BTMs 与种族和绝经状态相关,与硬化素的相关性不同。BTMs 与华裔美国人的硬化素无相关性。CTX 和骨碱性磷酸酶与硬化素呈正相关(r = 0.353,r = 0.458;均 P <.05)在白人绝经前女性中。相比之下,在绝经后白人女性中,硬化素与 I 型前胶原氨基端肽、5b 型抗酒石酸酸性磷酸酶和 CTX 的相关性为负(均 P <.05)。调整协变量后,硬化素与两种种族的面积 BMD 呈正相关。

结论

华裔美国女性的 BTMs 较低,而白人女性的 BTMs 与年龄相关的差异更大,为 BMD、微观结构和骨折的种族差异提供了生理学框架。

相似文献

1
Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.美国华裔女性和白人女性的循环骨硬化蛋白水平和骨转换标志物。
J Clin Endocrinol Metab. 2013 Dec;98(12):4736-43. doi: 10.1210/jc.2013-2106. Epub 2013 Sep 13.
2
Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.绝经前和绝经后妇女的传统和新型骨重塑标志物。
J Clin Endocrinol Metab. 2013 Nov;98(11):E1740-8. doi: 10.1210/jc.2013-2264. Epub 2013 Sep 3.
3
Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.接受糖皮质激素替代治疗的 Addison 病患者骨密度的预测因素。
Endocrine. 2024 May;84(2):711-719. doi: 10.1007/s12020-024-03709-3. Epub 2024 Feb 9.
4
Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.绝经后中国妇女血清骨硬化蛋白与 SOST 基因多态性与骨密度及骨代谢标志物的相关性。
J Clin Endocrinol Metab. 2014 Apr;99(4):E665-73. doi: 10.1210/jc.2013-2086. Epub 2014 Jan 1.
5
Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.维持性血液透析患者血清骨硬化蛋白与骨代谢标志物及骨密度的关系。
J Clin Endocrinol Metab. 2014 Nov;99(11):4315-20. doi: 10.1210/jc.2014-2372. Epub 2014 Aug 5.
6
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.地舒单抗对绝经后骨质疏松症患者骨转换标志物的影响。
J Bone Miner Res. 2011 Mar;26(3):530-7. doi: 10.1002/jbmr.251.
7
Relationship between plasma levels of sclerostin, calcium-phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients.血液透析患者的骨硬化蛋白、钙磷代谢紊乱、骨转换标志物和炎症的关系。
Int Urol Nephrol. 2019 Mar;51(3):519-526. doi: 10.1007/s11255-018-2050-3. Epub 2018 Dec 24.
8
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.绝经后妇女血清硬骨素与骨密度、骨转换、类固醇和甲状旁腺激素及骨折风险的关系:OFELY 研究。
Osteoporos Int. 2013 Feb;24(2):489-94. doi: 10.1007/s00198-012-1978-x. Epub 2012 Apr 14.
9
Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.慢性肾脏病透析患者骨量丢失的骨密度及血清生化预测指标
Clin J Am Soc Nephrol. 2014 Jul;9(7):1254-62. doi: 10.2215/CJN.09470913. Epub 2014 Jun 19.
10
Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.硬化蛋白在绝经后2型糖尿病中国女性骨质流失中的作用
Chin Med Sci J. 2013 Sep;28(3):135-9. doi: 10.1016/s1001-9294(13)60038-3.

引用本文的文献

1
Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait.评估科威特多民族人群中骨硬化蛋白水平与肥胖和 2 型糖尿病的相关性。
Front Endocrinol (Lausanne). 2024 Apr 22;15:1392675. doi: 10.3389/fendo.2024.1392675. eCollection 2024.
2
Osteoporosis and Fracture Risk among Older US Asian Adults.美国老年亚裔成年人的骨质疏松症和骨折风险。
Curr Osteoporos Rep. 2023 Oct;21(5):592-608. doi: 10.1007/s11914-023-00805-7. Epub 2023 Aug 5.
3
Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases.血清硬骨素及其与代谢性骨病骨转换标志物的关系。
Dis Markers. 2022 Sep 10;2022:7902046. doi: 10.1155/2022/7902046. eCollection 2022.
4
Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity.循环 SIRT1 和骨硬化蛋白与不同肥胖程度年轻女性的骨状态相关。
Nutrients. 2022 Feb 25;14(5):983. doi: 10.3390/nu14050983.
5
The association of circulating sclerostin level with markers of bone metabolism in patients with thyroid dysfunction.甲状腺功能障碍患者循环中骨硬化蛋白水平与骨代谢标志物的关联。
J Med Biochem. 2020 Oct 2;39(4):436-443. doi: 10.5937/jomb0-24943.
6
Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus.循环骨硬化蛋白与骨矿物质密度相关,与HIV血清学状态无关。
Bone Rep. 2020 May 11;12:100279. doi: 10.1016/j.bonr.2020.100279. eCollection 2020 Jun.
7
Sclerostin and Its Associations With Bone Metabolism Markers and Sex Hormones in Healthy Community-Dwelling Elderly Individuals and Adolescents.骨硬化蛋白及其与健康社区老年人和青少年骨代谢标志物及性激素的关联。
Front Cell Dev Biol. 2020 Feb 7;8:57. doi: 10.3389/fcell.2020.00057. eCollection 2020.
8
Response of Sclerostin and Bone Turnover Markers to High Intensity Interval Exercise in Young Women: Does Impact Matter?骨硬化蛋白和骨转换标志物对年轻女性高强度间歇训练的反应:冲击力重要吗?
Biomed Res Int. 2018 Nov 1;2018:4864952. doi: 10.1155/2018/4864952. eCollection 2018.
9
24-hour profile of serum sclerostin and its association with bone biomarkers in men.男性血清骨硬化蛋白 24 小时谱及其与骨生物标志物的关系。
Osteoporos Int. 2017 Nov;28(11):3205-3213. doi: 10.1007/s00198-017-4162-5. Epub 2017 Jul 26.
10
Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study.月经周期中血清硬化蛋白和Dickkopf-1水平的变化。一项初步研究。
Endocrine. 2016 Nov;54(2):543-551. doi: 10.1007/s12020-016-1056-9. Epub 2016 Sep 6.

本文引用的文献

1
Premenopausal and postmenopausal differences in bone microstructure and mechanical competence in Chinese-American and white women.中美两国绝经前和绝经后妇女的骨微观结构和力学性能差异。
J Bone Miner Res. 2013 Jun;28(6):1308-18. doi: 10.1002/jbmr.1860.
2
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.绝经后妇女血清硬骨素与骨密度、骨转换、类固醇和甲状旁腺激素及骨折风险的关系:OFELY 研究。
Osteoporos Int. 2013 Feb;24(2):489-94. doi: 10.1007/s00198-012-1978-x. Epub 2012 Apr 14.
3
Serum sclerostin and risk of hip fracture in older Caucasian women.血清骨硬化蛋白与老年白种人女性髋部骨折风险。
J Clin Endocrinol Metab. 2012 Jun;97(6):2027-32. doi: 10.1210/jc.2011-3419. Epub 2012 Mar 30.
4
Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.肥胖老年人群体中,体重减轻会导致血清硬骨素增加,并损害髋部结构,但运动训练可以预防这两种情况。
J Bone Miner Res. 2012 May;27(5):1215-21. doi: 10.1002/jbmr.1560.
5
Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.血清硬骨素水平与中南地区绝经后妇女的脂肪量和骨密度呈正相关。
Clin Endocrinol (Oxf). 2012 Jun;76(6):797-801. doi: 10.1111/j.1365-2265.2011.04315.x.
6
Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.骨硬化蛋白及其与健康成年人的体力活动、年龄、性别、身体成分和骨矿物质含量的关系。
J Clin Endocrinol Metab. 2012 Jan;97(1):148-54. doi: 10.1210/jc.2011-2152. Epub 2011 Oct 12.
7
Circulating sclerostin in disorders of parathyroid gland function.甲状旁腺功能障碍相关的循环骨硬化蛋白。
J Clin Endocrinol Metab. 2011 Dec;96(12):3804-10. doi: 10.1210/jc.2011-0566. Epub 2011 Sep 21.
8
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.单克隆抗体抑制骨硬化蛋白可促进骨愈合,并提高非骨折骨骼的骨密度和骨强度。
J Bone Miner Res. 2011 May;26(5):1012-21. doi: 10.1002/jbmr.307.
9
Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women.华裔美国女性的骨骼微观结构优于白种女性,这使她们具有更大的机械优势。
J Bone Miner Res. 2011 Aug;26(8):1783-92. doi: 10.1002/jbmr.378.
10
Differences in bone microarchitecture between postmenopausal Chinese-American and white women.绝经后华裔美国女性与白种女性的骨微观结构差异。
J Bone Miner Res. 2011 Jul;26(7):1392-8. doi: 10.1002/jbmr.352.